Gyre Therapeutics (GYRE) Return on Sales: 2009-2025
Historic Return on Sales for Gyre Therapeutics (GYRE) over the last 14 years, with Sep 2025 value amounting to 0.10%.
- Gyre Therapeutics' Return on Sales rose 91.00% to 0.10% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.10%, marking a year-over-year increase of 91.00%. This contributed to the annual value of 0.16% for FY2024, which is 92.00% up from last year.
- Per Gyre Therapeutics' latest filing, its Return on Sales stood at 0.10% for Q3 2025, which was up 33.21% from 0.08% recorded in Q2 2025.
- In the past 5 years, Gyre Therapeutics' Return on Sales registered a high of 0.17% during Q1 2023, and its lowest value of -14.01% during Q2 2021.
- In the last 3 years, Gyre Therapeutics' Return on Sales had a median value of -0.07% in 2023 and averaged -0.24%.
- Per our database at Business Quant, Gyre Therapeutics' Return on Sales tumbled by 1,156bps in 2021 and then surged by 1,218bps in 2023.
- Over the past 5 years, Gyre Therapeutics' Return on Sales (Quarterly) stood at -11.98% in 2021, then surged by 1,201bps to 0.03% in 2022, then slumped by 79bps to -0.76% in 2023, then soared by 92bps to 0.16% in 2024, then soared by 91bps to 0.10% in 2025.
- Its Return on Sales was 0.10% in Q3 2025, compared to 0.08% in Q2 2025 and 0.11% in Q1 2025.